Related Experiment Videos

Multi-pathway targeting by natural products in chronic respiratory diseases: Opportunities, challenges, and future

Siqi Lin1,2, Lili Li3, Shiqing Zhuo1,2

  • 1School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.

Insights

Natural products offer a multi-target approach for chronic respiratory diseases (CRDs) by modulating complex biological networks. Integrating systems biology, network pharmacology, and AI can advance their clinical use as next-generation CRD therapeutics.

Area of Science:

  • * Integrative medicine and pharmacology
  • * Computational biology and bioinformatics
  • * Natural product chemistry

Background:

  • * Chronic respiratory diseases (CRDs) involve complex, multifactorial pathologies including inflammation, oxidative stress, and tissue remodeling.
  • * Conventional single-target therapies are inadequate for managing CRD progression.
  • * There is a growing need for innovative therapeutic strategies to address the complexity of CRDs.

Purpose of the Study:

  • * To highlight the potential of natural products as multi-target therapeutics for CRDs.
  • * To emphasize the role of natural products as network modulators in complex diseases.
  • * To explore the integration of systems biology, network pharmacology, and artificial intelligence (AI) for understanding natural product mechanisms.

Main Methods:

  • * Review and synthesis of current research on natural products for CRDs.
  • * Conceptual framework integrating systems biology, network pharmacology, and AI.
  • * Discussion of strategies for clinical translation, including multi-omics, AI, targeted delivery, and blockchain.

Main Results:

  • * Natural products possess inherent multi-target properties suitable for complex diseases like CRDs.
  • * Network pharmacology and AI are essential tools for elucidating the polypharmacological effects of natural products.
  • * A network-centric approach is superior to reductionist methods for understanding CRD pathogenesis and treatment.

Conclusions:

  • * Natural products represent a promising therapeutic avenue for CRDs, acting as network modulators.
  • * The synergy of systems biology, network pharmacology, and AI is critical for unlocking their full potential.
  • * Strategic implementation of advanced technologies will facilitate the clinical translation of natural products for CRDs.

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation